Undervalued Drug Manufacturer Stocks on NAS November 2023

November 26, 2023

Drug Manufacturers

Drug Manufacturers are engaged in pharmaceutical manufacturing or sale of a diverse line of drug and healthcare products. This industry group also includes companies engaged in the development and discovery of new dugs, and tobacco and cannabis companies.

NASDAQ

The National Association of Securities Dealers Automated Quotations (Nasdaq) located in New York City, is the most active stock exchange by volume in the United States.

Our Valuation

A stock is considered undervalued if it trades at a discount to our valuation. To determine a stock’s intrinsic value, we developed an algorithm that uses 6 valuation models to determine the value of a company.* To learn more about stockcalc’s valuation methods, click here.

Undervalued Drug Manufacturers stocks

Stocks in this category are held primarily for potential income and capital appreciation.

For an in-depth look at the fundamentals and valuation of each company, try the stockcalc platform free for 30 days.

SymbolNameClose Price ($)Valuation ($)Difference (%)Average Vol (30D)Market Cap ($M)Yield (%)P/E Ratio
SBFM Sunshine Biopharma 0.28 0.85 204.01 171473 7 0.00 0.0
SNOA Sonoma Pharmaceuticals 0.17 0.43 152.70 635296 1 0.00 0.0
ACRX AcelRx Pharmaceuticals 0.69 1.60 131.73 109334 12 0.00 0.0
CLVR Clever Leaves Holdings 2.03 4.61 127.08 10539 3 0.00 0.0
ACOR Acorda Therapeutics 9.77 21.70 122.12 2661 12 0.00 3.7
TKNO Alpha Teknova 2.09 4.48 114.28 25084 63 0.00 0.0
SHPH Shuttle Pharmaceuticals 0.51 0.99 94.95 54363 8 0.00 0.0
UPC Universe Pharmaceuticals 1.04 2.02 94.40 17355 4 0.00 0.0
AKAN Akanda 0.45 0.87 93.16 53442 2 0.00 0.0
BFRI Biofrontera 3.20 5.99 87.07 20293 4 0.00 0.0
All data provided as at market close November 23, 2023.

Company Details

Sunshine Biopharma

SBFM:NAS

Close Price

0.28

Our Valuation

0.85

% Difference

204.01

Market Cap ($M)

7

P/E Ratio

0.0

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements.

Access the stockcalc valuation


Sonoma Pharmaceuticals

SNOA:NAS

Close Price

0.17

Our Valuation

0.43

% Difference

152.70

Market Cap ($M)

1

P/E Ratio

0.0

Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring.

Access the stockcalc valuation


AcelRx Pharmaceuticals

ACRX:NAS

Close Price

0.69

Our Valuation

1.60

% Difference

131.73

Market Cap ($M)

12

P/E Ratio

0.0

AcelRx Pharmaceuticals Inc is a specialty pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its product portfolio includes DSUVIA and Zalviso for Moderate-to-severe acute pain.

Access the stockcalc valuation


Clever Leaves Holdings

CLVR:NAS

Close Price

2.03

Our Valuation

4.61

% Difference

127.08

Market Cap ($M)

3

P/E Ratio

0.0

Clever Leaves Holdings Inc is a producer of pharmaceutical and consumer cannabis brands. The company operates and has investments in Canada, Colombia, Germany, Portugal, and the United States. The company operates in two reportable segments, 1. The Cannabinoid operating segment: is comprised of the Company's cultivation, extraction, and commercialization of cannabinoid products. 2.

Access the stockcalc valuation


Access our valuation for these companies and 9,000+ more

Try the stockcalc platform free for 30 days

Sign Up

Acorda Therapeutics

ACOR:NAS

Close Price

9.77

Our Valuation

21.70

% Difference

122.12

Market Cap ($M)

12

P/E Ratio

3.7

Acorda Therapeutics Inc is a biopharmaceutical company engaged in developing therapies that restore function and improve the lives of people with neurological disorders. The company market Inbrija (levodopa inhalation powder), which is approved in the U.S. for intermittent treatment of OFF episodes, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa.

Access the stockcalc valuation


Alpha Teknova

TKNO:NAS

Close Price

2.09

Our Valuation

4.48

% Difference

114.28

Market Cap ($M)

63

P/E Ratio

0.0

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification.

Access the stockcalc valuation


Shuttle Pharmaceuticals

SHPH:NAS

Close Price

0.51

Our Valuation

0.99

% Difference

94.95

Market Cap ($M)

8

P/E Ratio

0.0

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy.

Access the stockcalc valuation


Universe Pharmaceuticals

UPC:NAS

Close Price

1.04

Our Valuation

2.02

% Difference

94.40

Market Cap ($M)

4

P/E Ratio

0.0

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies.

Access the stockcalc valuation


Akanda

AKAN:NAS

Close Price

0.45

Our Valuation

0.87

% Difference

93.16

Market Cap ($M)

2

P/E Ratio

0.0

Akanda Corp is a cannabis cultivation, manufacturing and distribution company. The Company has three reportable segments: Cultivation, Distribution and Corporate. Cultivating activities comprise the cultivation segment is made up of the medical cannabis cultivation operations at RPK/Holigen in Portugal, and medical cannabis cultivation activities. Distributing activities relate to the distribution of medical cannabis by Canmart Ltd in the United Kingdom.

Access the stockcalc valuation


Biofrontera

BFRI:NAS

Close Price

3.20

Our Valuation

5.99

% Difference

87.07

Market Cap ($M)

4

P/E Ratio

0.0

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.

Access the stockcalc valuation


Access thousands of valuation reports

Try the stockcalc platform for 30 days for unlimited access to our valuation reports

Sign Up
Sunshine Biopharma and Sonoma Pharmaceuticals are the most undervalued Drug Manufacturers stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-november-2023
Sunshine Biopharma $SBFM and Sonoma Pharmaceuticals $SNOA are the most undervalued Drug Manufacturers stocks on the #NAS. See the full list: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-november-2023
Sunshine Biopharma and Sonoma Pharmaceuticals are the most undervalued Drug Manufacturers stocks on the NAS. See the full list on the blog: https://www.stockcalc.com/Blog/undervalued-drug-manufacturer-stocks-nas-november-2023

Copyright © 2016- Patchell Brook Equity Analytics Inc. All rights reserved.

Risk Disclosure: Equities trading and trading of all markets, exchanges and instruments contains substantial risk and is not for every investor. An investor could potentially lose all or more than the initial investment. Risk capital is money that can be lost without jeopardizing ones’ financial security or life style. Only risk capital should be used for trading and only those with sufficient risk capital should consider trading. Past performance is not necessarily indicative of future results. View full risk information here.